• Rational Design Enhances NIR-II IR-1061 Liposome Imaging Per

  2026-06-08

  The referenced study demonstrates that optimizing the charge properties and concentration of IR-1061 within liposomal nanosystems substantially improves near-infrared (NIR-II) fluorescence intensity and vascular imaging duration in vivo. These findings clarify design principles for maximizing deep tissue imaging contrast and persistence using organic fluorophores.

• WY-14643 (Pirinixic Acid): Optimizing PPARα Metabolic Resear

  2026-06-07

  WY-14643 (Pirinixic Acid) empowers precision research into PPARα-driven pathways, advancing models of lipid metabolism, inflammation, and liver regeneration. This guide delivers actionable protocols, troubleshooting insights, and highlights a pivotal study that redefines experimental strategies for metabolic disorder research.

• Tirbanibulin Suppresses HPV Oncoproteins via Src-MEK Pathway

  2026-06-06

  This study demonstrates that tirbanibulin markedly inhibits cell proliferation and downregulates oncogenic signaling—including HPV E6 and E7 proteins—in HPV-18–positive HeLa cells. By targeting the Src-MEK axis, tirbanibulin disrupts multiple cancer-related pathways and enhances apoptosis, yielding insights relevant for antiviral and oncology research.

• Applied Cancer & Hypoxia Research with YC-1: Workflow and Ti

  2026-06-05

  YC-1 (5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol empowers researchers to dissect hypoxia-inducible signaling and tumor angiogenesis with high reproducibility. This article delivers advanced workflows and troubleshooting strategies, highlighting how APExBIO’s high-purity YC-1 enables both cancer biology and neuroprotection models.

• Cyclic Pifithrin-α Hydrobromide: Applied p53 Inhibition Work

  2026-06-05

  Cyclic Pifithrin-α hydrobromide enables precise, selective p53 inhibition for dissecting apoptosis pathways and modulating DNA damage responses in advanced cancer and neuroinflammatory research. This article delivers stepwise protocols, troubleshooting advice, and insight into recent neuroinflammatory models, equipping scientists to deploy APExBIO's reagent with confidence.

• YAP-TEAD is Essential for PPARα-Induced Liver Regeneration i

  2026-06-04

  This study demonstrates that activation of PPARα by WY-14643 (Pirinixic Acid) promotes hepatomegaly and liver regeneration in mice through a YAP-TEAD dependent mechanism. The findings establish a mechanistic bridge between metabolic regulation and regenerative signaling, with practical implications for liver disease and metabolic disorder research.

• Multilineage Organoids Enable Pan-Genotype HEV Research Plat

  2026-06-04

  This study pioneers the use of iPSC-derived liver, intestinal, and brain organoids to model the full life cycle and tissue tropism of hepatitis E virus (HEV) genotypes 1, 3, and 4. The approach overcomes previous limitations in HEV research models, facilitating improved virology, pathogenesis, and antiviral drug testing in physiologically relevant systems.

• U 46619: Selective Platelet Aggregation Inducer and Vascular

  2026-06-03

  U 46619 (11,9 epoxymethano-prostaglandin H2) is a synthetic, selective prostaglandin H2/thromboxane A2 receptor agonist used to induce platelet aggregation and model cardiovascular responses. Its nanomolar EC50 for platelet shape change and precise solubility profile make it a benchmark tool in vascular and renal research. Supplied by APExBIO, it is intended strictly for research applications.

• Licoricidin Inhibits HCC Growth and Metastasis via PI3K/AKT

  2026-06-03

  This study establishes licoricidin, a prenylated isoflavone from licorice, as a potent inhibitor of hepatocellular carcinoma (HCC) growth and metastasis through targeted suppression of the PI3K/AKT pathway. The findings highlight key mechanisms of cell cycle arrest, apoptosis induction, and epithelial-mesenchymal transition regulation that may inform both basic research and the development of new HCC therapies.

• BRD4 Inhibition Enhances Ferroptosis via ROS and FSP1 Modula

  2026-06-02

  The referenced study demonstrates that BRD4 inhibitors, including I-BET-762, broadly sensitize various cancer cell lines to erastin-induced ferroptosis by promoting reactive oxygen species (ROS) accumulation and downregulating FSP1. These mechanistic insights clarify the role of BET protein inhibition in ferroptosis and suggest new research avenues for combination strategies in cancer biology.

• Scenario-Driven Solutions: DiscoveryProbe™ Bioactive Compoun

  2026-06-02

  This article addresses real-world laboratory challenges in cell viability, apoptosis, and pathway screening using the rigorously validated DiscoveryProbe™ Bioactive Compound Library Plus (SKU: L1022P). Through five scenario-based Q&A blocks, we demonstrate how SKU L1022P empowers reproducible, efficient, and high-content screening for modern biomedical research.

• Mitochondrial NAD+ Deficiency Drives Aortic Aneurysm via Col

  2026-06-01

  This study identifies mitochondrial NAD+ deficiency in vascular smooth muscle cells as a key driver of thoracic and abdominal aortic aneurysm, mechanistically linked to impaired collagen III turnover and proline biosynthesis. Multiomics and genetic analyses reveal NAD+ transporter SLC25A51 as a critical determinant of disease risk, providing new molecular targets for vascular research.

• Rotigotine Hydrochloride: Dopamine D2/D3 Receptor Agonist Be

  2026-06-01

  Rotigotine hydrochloride is a full dopamine D2/D3 receptor agonist with high selectivity, validated for both in vitro and in vivo models of Parkinson’s disease. Evidence shows it modulates motor and non-motor symptoms, including bladder dysfunction, via well-characterized mechanisms. This dossier details protocol parameters, efficacy benchmarks, and usage limitations relevant for dopaminergic signaling research.

• Rotenone as a Mitochondrial Complex I Inhibitor in PD Models

  2026-05-31

  Rotenone empowers researchers to model mitochondrial dysfunction and neurodegenerative pathology with high fidelity. This article details stepwise experimental design, troubleshooting, and translational insights for leveraging APExBIO’s rotenone in Parkinson’s disease and autophagy pathway research.

• Halazone’s Dual Role: From Water Disinfection to Ion Channel

  2026-05-30

  Explore Halazone as a broad-spectrum antimicrobial sulfonamide derivative with unique mechanisms for both water disinfection and neuronal sodium channel modulation. This article delivers deep mechanistic insights and practical protocols, distinguishing itself from existing guides by focusing on molecular action and assay decision-making.

612 records 11/41 page Previous Next First page 上5页 1112131415 下5页 Last page